Penserra Capital Management’s Regenxbio RGNX Stock Holding History

Penserra Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-975	Closed	-$40K	–	1517
2021 Q3	$40K	Buy	975 +5	+0.5%	+$180	﹤0.01%	1113
2021 Q2	$37K	Buy	970 +15	+2%	+$536	﹤0.01%	1067
2021 Q1	$32K	Buy	955 +95	+11%	+$4.05K	﹤0.01%	893
2020 Q4	$39K	Buy	860 +540	+169%	+$18.9K	﹤0.01%	733
2020 Q3	$8K	Buy	+320	New	+$10.4K	﹤0.01%	838
2018 Q3	–	Sell	-1,692	Closed	-$121K	–	736
2018 Q2	$121K	Buy	+1,692	New	+$80.8K	0.01%	337

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Penserra Capital Management's RGNX Position: Q4 2021 in Review

Penserra Capital Management sold out of Regenxbio (RGNX) in Q4 2021, closing a stake of 975 shares — an estimated $40K sold.

Penserra Capital Management first reported a position in RGNX in Q2 2018 and held it in 6 quarters. The position peaked at $121K in Q2 2018. 172 funds tracked by Wall St. Rank hold RGNX as of Q4 2021.

Penserra Capital Management reported no remaining Regenxbio position as of Q4 2021 after selling out during the quarter.
Penserra Capital Management sold 975 Regenxbio shares in Q4 2021, an estimated $40K.
Penserra Capital Management first reported a position in Regenxbio in Q2 2018 and held it in 6 quarters.
Penserra Capital Management's Regenxbio position peaked at $121K in Q2 2018.
172 funds tracked by Wall St. Rank held Regenxbio as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.